Ting Cao

Guangzhou University of Chinese Medicine

H指数:16

被引数:1,056

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Identification and Validation of Novel Biomarkers for Unstable Angina Using Olink Proteomics

JOURNAL OF PROTEOME RESEARCH

IF3.6

2025-12-010

PRE

Liraglutide attenuates clozapine-induced mitochondrial dysfunction and improves energy metabolism in the brain of rats

利拉鲁肽减轻氯氮平诱导的线粒体功能障碍，并改善大鼠脑内的能量代谢。

Biochemical Pharmacology

IF5.6

2025-06-280

PRE

Bioenergetic biomarkers as predictive indicators and their relationship with cognitive function in newly diagnosed, drug-naïve patients with bipolar disorder

生物能量学生物标志物作为预测指标，及其与初诊、药物未治疗的双相障碍患者认知功能的关系

TRANSLATIONAL PSYCHIATRY

IF6.2

2025-04-140

Akkermansia muciniphila ameliorates olanzapine-induced metabolic dysfunction-associated steatotic liver disease via PGRMC1/SIRT1/FOXO1 signaling pathway

Akkermansia muciniphila通过PGRMC1/SIRT1/FOXO1信号通路改善奥氮平诱导的代谢功能障碍相关脂肪性肝病。

FRONTIERS IN PHARMACOLOGY

IF4.8

2025-03-190

Differential impact of intermittent versus continuous treatment with clozapine on fatty acid metabolism in the brain of an MK-801-induced mouse model of schizophrenia

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

IF3.9

2024-07-010

PRE

Association of weight-adjusted waist index with all-cause mortality among non-Asian individuals: a national population-based cohort study

NUTRITION JOURNAL

IF3.8

2024-06-126

OAAI

B-GOS alleviates olanzapine-induced lipid disturbances in mice by enriching Akkermansia and upregulation of PGRMC1-Wnt signaling

FOOD AND CHEMICAL TOXICOLOGY

IF3.5

2024-03-011

PRE

Long non-coding RNAs in schizophrenia: Genetic variations, treatment markers and potential targeted signaling pathways

SCHIZOPHRENIA RESEARCH

IF3.5

2023-10-013

PRE

Olanzapine-induced nonalcoholic fatty liver disease: The effects of differential food pattern and the involvement of PGRMC1 signaling

FOOD AND CHEMICAL TOXICOLOGY

IF3.5

2023-06-017

PRE

Insight into mitochondrial dysfunction mediated by clozapine-induced inhibition of PGRMC1 in PC12 cells

TOXICOLOGY

IF4.6

2023-06-012

PRE

Diminished treatment response in relapsed versus first-episode schizophrenia as revealed by a panel of blood-based biomarkers: A combined cross-sectional and longitudinal study

一组基于血液的生物标志物显示，复发与首发精神分裂症的治疗反应减弱: 一项横断面和纵向联合研究

PSYCHIATRY RESEARCH

IF3.9

2022-10-015

PRE

Disturbance of neurotransmitter metabolism in drug-naive, first-episode major depressive disorder: a comparative study on adult and adolescent cohorts

EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE

IF3.7

2022-04-1113

PRE

Reduced erythrocyte membrane polyunsaturated fatty acid levels indicate diminished treatment response in patients with multi-versus first-episode schizophrenia

SCHIZOPHRENIA

IF4.1

2022-02-2523

OAAI

Clozapine Induced Disturbances in Hepatic Glucose Metabolism: The Potential Role of PGRMC1 Signaling

FRONTIERS IN ENDOCRINOLOGY

IF4.6

2021-12-149

OAAI

Integrated driver mutations profile of Chinese NK/T cell lymphoma

ANNALS OF ONCOLOGY

IF65.4

2021-09-010

Gut microbiota: An intermediary between metabolic syndrome and cognitive deficits in schizophrenia

PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

IF3.9

2021-03-0123

PREAI

Candidatemetabolic biomarkers for schizophrenia in CNS and periphery: Do any possible associations exist?

SCHIZOPHRENIA RESEARCH

IF3.5

2020-12-0120

PREAI

Quantitative monitoring of a panel of stress-induced biomarkers in human plasma by liquid chromatography-tandem mass spectrometry: an application in a comparative study between depressive patients and healthy subjects

ANALYTICAL AND BIOANALYTICAL CHEMISTRY

IF3.8

2019-06-1413

PREAI

Neurosteroids in Schizophrenia: Pathogenic and Therapeutic Implications

FRONTIERS IN PSYCHIATRY

IF3.2

2018-03-0851

OAAI

Telmisartan prevents weight gain and obesity through activation of PPAR-δ dependent lipolytic pathways

INTERNATIONAL JOURNAL OF CARDIOLOGY

IF3.2

2009-10-010

OAAI

Ting Cao

个人简介

教育背景

工作经历

荣誉奖项

研究方向